

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | desmosome organization (GO:0002934) | 7.53588087 |
| 2 | angiotensin maturation (GO:0002003) | 7.25446067 |
| 3 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 7.10442024 |
| 4 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 6.37120269 |
| 5 | vitamin transmembrane transport (GO:0035461) | 6.11232940 |
| 6 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 6.05104077 |
| 7 | rRNA catabolic process (GO:0016075) | 5.98833556 |
| 8 | positive regulation of prostaglandin secretion (GO:0032308) | 5.75249482 |
| 9 | keratinization (GO:0031424) | 5.58907115 |
| 10 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 5.31847238 |
| 11 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 5.31847238 |
| 12 | carnitine shuttle (GO:0006853) | 5.27450151 |
| 13 | NADH metabolic process (GO:0006734) | 5.25666318 |
| 14 | negative regulation of cholesterol transport (GO:0032375) | 5.05391695 |
| 15 | negative regulation of sterol transport (GO:0032372) | 5.05391695 |
| 16 | flavonoid metabolic process (GO:0009812) | 5.04184814 |
| 17 | regulation of prostaglandin secretion (GO:0032306) | 4.91636140 |
| 18 | intestinal absorption (GO:0050892) | 4.90058270 |
| 19 | maintenance of gastrointestinal epithelium (GO:0030277) | 4.84587809 |
| 20 | epoxygenase P450 pathway (GO:0019373) | 4.81947729 |
| 21 | bile acid and bile salt transport (GO:0015721) | 4.81285143 |
| 22 | antimicrobial humoral response (GO:0019730) | 4.75671308 |
| 23 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.65940159 |
| 24 | antibacterial humoral response (GO:0019731) | 4.54094808 |
| 25 | intestinal epithelial cell development (GO:0060576) | 4.47619627 |
| 26 | histone-serine phosphorylation (GO:0035404) | 4.46946925 |
| 27 | hepatocyte apoptotic process (GO:0097284) | 4.43549035 |
| 28 | fatty acid homeostasis (GO:0055089) | 4.43292142 |
| 29 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 4.41017934 |
| 30 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.40064138 |
| 31 | regulation of energy homeostasis (GO:2000505) | 4.38213154 |
| 32 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.36808424 |
| 33 | endocrine process (GO:0050886) | 4.36808424 |
| 34 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.36808424 |
| 35 | actin filament depolymerization (GO:0030042) | 4.27913997 |
| 36 | fatty acid transmembrane transport (GO:1902001) | 4.24752006 |
| 37 | sulfur amino acid catabolic process (GO:0000098) | 4.23195831 |
| 38 | lipoprotein transport (GO:0042953) | 4.19142602 |
| 39 | positive regulation of icosanoid secretion (GO:0032305) | 4.17196333 |
| 40 | cellular glucuronidation (GO:0052695) | 4.17131759 |
| 41 | regulation of bile acid biosynthetic process (GO:0070857) | 4.16390910 |
| 42 | hemidesmosome assembly (GO:0031581) | 4.15617182 |
| 43 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 4.14137274 |
| 44 | renal system process involved in regulation of blood volume (GO:0001977) | 4.12185877 |
| 45 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 4.11235036 |
| 46 | regulation of water loss via skin (GO:0033561) | 4.08654499 |
| 47 | urea cycle (GO:0000050) | 4.06744912 |
| 48 | regulation of cellular extravasation (GO:0002691) | 4.05411418 |
| 49 | positive regulation of respiratory burst (GO:0060267) | 4.04528832 |
| 50 | carnitine transmembrane transport (GO:1902603) | 4.04253417 |
| 51 | positive regulation of glycolytic process (GO:0045821) | 4.01959969 |
| 52 | sulfate transmembrane transport (GO:1902358) | 3.97960094 |
| 53 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.97827637 |
| 54 | epithelial structure maintenance (GO:0010669) | 3.93601061 |
| 55 | fructose metabolic process (GO:0006000) | 3.92860198 |
| 56 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.92639292 |
| 57 | regulation of systemic arterial blood pressure (GO:0003073) | 3.92597400 |
| 58 | urea metabolic process (GO:0019627) | 3.91013448 |
| 59 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 3.85745084 |
| 60 | drug metabolic process (GO:0017144) | 3.82827891 |
| 61 | regulation of guanylate cyclase activity (GO:0031282) | 3.81969929 |
| 62 | regulation of cholesterol efflux (GO:0010874) | 3.78961049 |
| 63 | establishment of skin barrier (GO:0061436) | 3.78289665 |
| 64 | phospholipid efflux (GO:0033700) | 3.77428984 |
| 65 | amino-acid betaine transport (GO:0015838) | 3.75992253 |
| 66 | carnitine transport (GO:0015879) | 3.75992253 |
| 67 | regulation of triglyceride catabolic process (GO:0010896) | 3.74658367 |
| 68 | diacylglycerol metabolic process (GO:0046339) | 3.67984909 |
| 69 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.66583503 |
| 70 | regulation of T cell tolerance induction (GO:0002664) | 3.65269248 |
| 71 | glomerular filtration (GO:0003094) | 3.64986010 |
| 72 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 3.62762833 |
| 73 | galactose catabolic process (GO:0019388) | 3.61573056 |
| 74 | sulfur compound transport (GO:0072348) | 3.60371992 |
| 75 | glucuronate metabolic process (GO:0019585) | 3.60353299 |
| 76 | uronic acid metabolic process (GO:0006063) | 3.60353299 |
| 77 | nitrogen cycle metabolic process (GO:0071941) | 3.59911218 |
| 78 | hormone catabolic process (GO:0042447) | 3.59340337 |
| 79 | regulation of cholesterol homeostasis (GO:2000188) | 3.59054118 |
| 80 | positive regulation of pseudopodium assembly (GO:0031274) | 3.54379518 |
| 81 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.49600316 |
| 82 | renal filtration (GO:0097205) | 3.47791836 |
| 83 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.43556310 |
| 84 | phosphatidylserine metabolic process (GO:0006658) | 3.41538810 |
| 85 | positive regulation of fatty acid transport (GO:2000193) | 3.40731666 |
| 86 | hypotonic response (GO:0006971) | 3.40443175 |
| 87 | cellular response to glucose starvation (GO:0042149) | 3.36934911 |
| 88 | regulation of cGMP biosynthetic process (GO:0030826) | 3.35771567 |
| 89 | water homeostasis (GO:0030104) | 3.35622948 |
| 90 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.31792136 |
| 91 | macrophage chemotaxis (GO:0048246) | 3.29090542 |
| 92 | digestion (GO:0007586) | 3.28340035 |
| 93 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.27879454 |
| 94 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.27783008 |
| 95 | oligosaccharide biosynthetic process (GO:0009312) | 3.26752206 |
| 96 | sulfation (GO:0051923) | 3.24571493 |
| 97 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.24003177 |
| 98 | peptide catabolic process (GO:0043171) | 3.21650975 |
| 99 | sulfate transport (GO:0008272) | 3.21030167 |
| 100 | intermediate filament organization (GO:0045109) | 3.19979921 |
| 101 | plasma lipoprotein particle assembly (GO:0034377) | 3.18636364 |
| 102 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.12478774 |
| 103 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.12255060 |
| 104 | virion attachment to host cell (GO:0019062) | 3.11727185 |
| 105 | adhesion of symbiont to host cell (GO:0044650) | 3.11727185 |
| 106 | ethanol oxidation (GO:0006069) | 3.10962796 |
| 107 | glycolipid catabolic process (GO:0019377) | 3.10498428 |
| 108 | bicarbonate transport (GO:0015701) | 3.10410319 |
| 109 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.10107427 |
| 110 | regulation of cholesterol transport (GO:0032374) | 3.08274008 |
| 111 | regulation of sterol transport (GO:0032371) | 3.08274008 |
| 112 | arginine metabolic process (GO:0006525) | 3.07328747 |
| 113 | vitamin A metabolic process (GO:0006776) | 3.06876284 |
| 114 | GDP-mannose metabolic process (GO:0019673) | 3.06639654 |
| 115 | regulation of pseudopodium assembly (GO:0031272) | 3.05782638 |
| 116 | positive regulation of lipid catabolic process (GO:0050996) | 3.05063319 |
| 117 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.04598791 |
| 118 | glycosphingolipid catabolic process (GO:0046479) | 3.04191232 |
| 119 | cGMP-mediated signaling (GO:0019934) | 3.01405620 |
| 120 | protein-lipid complex assembly (GO:0065005) | 3.01184446 |
| 121 | digestive system process (GO:0022600) | 3.01101800 |
| 122 | transcytosis (GO:0045056) | 2.99694282 |
| 123 | positive regulation of lipid storage (GO:0010884) | 2.99308336 |
| 124 | morphogenesis of an epithelial fold (GO:0060571) | 2.97952702 |
| 125 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.95497537 |
| 126 | auditory receptor cell differentiation (GO:0042491) | 2.94979464 |
| 127 | regulation of icosanoid secretion (GO:0032303) | 2.94613672 |
| 128 | peptide hormone processing (GO:0016486) | 2.93106183 |
| 129 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.92687410 |
| 130 | intracellular lipid transport (GO:0032365) | 2.92224384 |
| 131 | respiratory tube development (GO:0030323) | 2.91558693 |
| 132 | alditol phosphate metabolic process (GO:0052646) | 2.90021900 |
| 133 | regulation of cholesterol esterification (GO:0010872) | 2.88991866 |
| 134 | sphingomyelin metabolic process (GO:0006684) | 2.88986685 |
| 135 | epithelial cell-cell adhesion (GO:0090136) | 2.88426939 |
| 136 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.88162099 |
| 137 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.88162099 |
| 138 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.84602805 |
| 139 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.83475231 |
| 140 | cyclooxygenase pathway (GO:0019371) | 2.82171672 |
| 141 | lipoprotein metabolic process (GO:0042157) | 2.82024836 |
| 142 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 2.80305476 |
| 143 | phosphatidylcholine biosynthetic process (GO:0006656) | 2.79325064 |
| 144 | drug catabolic process (GO:0042737) | 2.77938492 |
| 145 | regulation of interleukin-1 secretion (GO:0050704) | 2.77747538 |
| 146 | sodium ion homeostasis (GO:0055078) | 2.77471130 |
| 147 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.76674819 |
| 148 | regulation of vitamin metabolic process (GO:0030656) | 2.76087532 |
| 149 | O-glycan processing (GO:0016266) | 2.75571879 |
| 150 | positive regulation of cGMP metabolic process (GO:0030825) | 2.74635825 |
| 151 | alkaloid metabolic process (GO:0009820) | 2.74109125 |
| 152 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.73874810 |
| 153 | glycosylceramide metabolic process (GO:0006677) | 2.73854640 |
| 154 | intestinal cholesterol absorption (GO:0030299) | 2.72782726 |
| 155 | ventricular septum development (GO:0003281) | 2.71971954 |
| 156 | multicellular organismal water homeostasis (GO:0050891) | 2.71778153 |
| 157 | regulation of cGMP metabolic process (GO:0030823) | 2.69693754 |
| 158 | positive regulation of tolerance induction (GO:0002645) | 2.69550345 |
| 159 | regulation of cholesterol metabolic process (GO:0090181) | 2.66594478 |
| 160 | regulation of respiratory burst (GO:0060263) | 2.66541914 |
| 161 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.66535954 |
| 162 | regulation of proton transport (GO:0010155) | 2.64883932 |
| 163 | phosphatidylcholine metabolic process (GO:0046470) | 2.64825150 |
| 164 | phospholipid transport (GO:0015914) | 2.63996886 |
| 165 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.61363346 |
| 166 | negative regulation of protein oligomerization (GO:0032460) | 2.60987558 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 9.96789316 |
| 2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.99806954 |
| 3 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 3.34414589 |
| 4 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.24274846 |
| 5 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 3.22661123 |
| 6 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 3.17129833 |
| 7 | * SOX2_20726797_ChIP-Seq_SW620_Human | 2.85489055 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.74263471 |
| 9 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.55427454 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.45572361 |
| 11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.44799227 |
| 12 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.35624927 |
| 13 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.27422968 |
| 14 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.25008190 |
| 15 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.22202620 |
| 16 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.07287865 |
| 17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.00760345 |
| 18 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.99144102 |
| 19 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.93180633 |
| 20 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.91766966 |
| 21 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.90070056 |
| 22 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.86875104 |
| 23 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.85201850 |
| 24 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.81178674 |
| 25 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.76785436 |
| 26 | ATF3_27146783_Chip-Seq_COLON_Human | 1.74965564 |
| 27 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.74901271 |
| 28 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.74643654 |
| 29 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.69931557 |
| 30 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.67434530 |
| 31 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.64343330 |
| 32 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.63519422 |
| 33 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.62644560 |
| 34 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.62010251 |
| 35 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.62010251 |
| 36 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.58941253 |
| 37 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.55259415 |
| 38 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.55162587 |
| 39 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.53091385 |
| 40 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.52724987 |
| 41 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.52005110 |
| 42 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.47599623 |
| 43 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.46818808 |
| 44 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.45837592 |
| 45 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.45626514 |
| 46 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.43170299 |
| 47 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.37267413 |
| 48 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.37210396 |
| 49 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.36936582 |
| 50 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.33616548 |
| 51 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.24639800 |
| 52 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.22773898 |
| 53 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.22751035 |
| 54 | * PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.22647497 |
| 55 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.20886679 |
| 56 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.18517768 |
| 57 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.15693803 |
| 58 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.15638890 |
| 59 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.15093163 |
| 60 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.14883544 |
| 61 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.12307134 |
| 62 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.10090035 |
| 63 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09160093 |
| 64 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.08585025 |
| 65 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.07280254 |
| 66 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.06572121 |
| 67 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06398563 |
| 68 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.06099301 |
| 69 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.04471544 |
| 70 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.04144226 |
| 71 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.03721732 |
| 72 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.02376186 |
| 73 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00434444 |
| 74 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.00178093 |
| 75 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.00009783 |
| 76 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.98311257 |
| 77 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98202964 |
| 78 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.97551675 |
| 79 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.97512803 |
| 80 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.96886441 |
| 81 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.96153092 |
| 82 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.95765381 |
| 83 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95070485 |
| 84 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.94490058 |
| 85 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.93634768 |
| 86 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.93116668 |
| 87 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.92608832 |
| 88 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.92551359 |
| 89 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.92374486 |
| 90 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.92264093 |
| 91 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.92069317 |
| 92 | * GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.91716419 |
| 93 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91607433 |
| 94 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.91279753 |
| 95 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.90810923 |
| 96 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.90664460 |
| 97 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.90500123 |
| 98 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.89192966 |
| 99 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.88936502 |
| 100 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.88670208 |
| 101 | RXR_22108803_ChIP-Seq_LS180_Human | 0.88415470 |
| 102 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.87658534 |
| 103 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.86843786 |
| 104 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.86438792 |
| 105 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.86238531 |
| 106 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.85639527 |
| 107 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.85394079 |
| 108 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.85348123 |
| 109 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.84777505 |
| 110 | GATA1_19941826_ChIP-Seq_K562_Human | 0.84601589 |
| 111 | SA1_27219007_Chip-Seq_Bcells_Human | 0.83323853 |
| 112 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.83006391 |
| 113 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.82588200 |
| 114 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.81997019 |
| 115 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.81965645 |
| 116 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.81587957 |
| 117 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.81106862 |
| 118 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.80303491 |
| 119 | GATA2_19941826_ChIP-Seq_K562_Human | 0.80242331 |
| 120 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80220109 |
| 121 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.80141345 |
| 122 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.79705211 |
| 123 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.79596177 |
| 124 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.79596177 |
| 125 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78979419 |
| 126 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.78617991 |
| 127 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.77853743 |
| 128 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.77422523 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 8.59255850 |
| 2 | MP0002822_catalepsy | 4.65887770 |
| 3 | MP0003878_abnormal_ear_physiology | 4.28217158 |
| 4 | MP0005377_hearing/vestibular/ear_phenot | 4.28217158 |
| 5 | MP0001873_stomach_inflammation | 3.37989312 |
| 6 | MP0009379_abnormal_foot_pigmentation | 3.17974313 |
| 7 | MP0003866_abnormal_defecation | 3.14226130 |
| 8 | MP0004264_abnormal_extraembryonic_tissu | 3.12430449 |
| 9 | MP0005365_abnormal_bile_salt | 2.84410481 |
| 10 | MP0003283_abnormal_digestive_organ | 2.77056312 |
| 11 | MP0000462_abnormal_digestive_system | 2.71083828 |
| 12 | MP0003183_abnormal_peptide_metabolism | 2.68596271 |
| 13 | MP0002796_impaired_skin_barrier | 2.68586428 |
| 14 | MP0000537_abnormal_urethra_morphology | 2.45404286 |
| 15 | MP0010155_abnormal_intestine_physiology | 2.34557122 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.29832776 |
| 17 | MP0003941_abnormal_skin_development | 2.29764428 |
| 18 | MP0005409_darkened_coat_color | 2.22725195 |
| 19 | MP0005167_abnormal_blood-brain_barrier | 2.16442718 |
| 20 | MP0001663_abnormal_digestive_system | 2.13072090 |
| 21 | MP0005381_digestive/alimentary_phenotyp | 2.06576628 |
| 22 | MP0010352_gastrointestinal_tract_polyps | 2.04053673 |
| 23 | MP0001664_abnormal_digestion | 2.03821510 |
| 24 | MP0002909_abnormal_adrenal_gland | 2.01601470 |
| 25 | MP0004147_increased_porphyrin_level | 1.98936683 |
| 26 | MP0000516_abnormal_urinary_system | 1.97081198 |
| 27 | MP0005367_renal/urinary_system_phenotyp | 1.97081198 |
| 28 | MP0005257_abnormal_intraocular_pressure | 1.96867469 |
| 29 | MP0000477_abnormal_intestine_morphology | 1.89038220 |
| 30 | MP0010678_abnormal_skin_adnexa | 1.86514865 |
| 31 | MP0003315_abnormal_perineum_morphology | 1.81739663 |
| 32 | MP0004947_skin_inflammation | 1.72995737 |
| 33 | MP0003453_abnormal_keratinocyte_physiol | 1.72217598 |
| 34 | MP0008875_abnormal_xenobiotic_pharmacok | 1.70474108 |
| 35 | MP0000579_abnormal_nail_morphology | 1.70383901 |
| 36 | MP0000490_abnormal_crypts_of | 1.69180534 |
| 37 | MP0008004_abnormal_stomach_pH | 1.65183404 |
| 38 | MP0003300_gastrointestinal_ulcer | 1.60783341 |
| 39 | MP0005501_abnormal_skin_physiology | 1.60644258 |
| 40 | MP0003191_abnormal_cellular_cholesterol | 1.60381942 |
| 41 | MP0010329_abnormal_lipoprotein_level | 1.57327195 |
| 42 | MP0001216_abnormal_epidermal_layer | 1.52614599 |
| 43 | MP0009785_altered_susceptibility_to | 1.49503665 |
| 44 | MP0003705_abnormal_hypodermis_morpholog | 1.45351953 |
| 45 | MP0005085_abnormal_gallbladder_physiolo | 1.43800530 |
| 46 | MP0005360_urolithiasis | 1.42515892 |
| 47 | MP0002876_abnormal_thyroid_physiology | 1.36430821 |
| 48 | MP0002060_abnormal_skin_morphology | 1.36023195 |
| 49 | MP0005332_abnormal_amino_acid | 1.35561888 |
| 50 | MP0004130_abnormal_muscle_cell | 1.31180159 |
| 51 | MP0000566_synostosis | 1.30493119 |
| 52 | MP0005451_abnormal_body_composition | 1.29119539 |
| 53 | MP0005076_abnormal_cell_differentiation | 1.28386445 |
| 54 | MP0000538_abnormal_urinary_bladder | 1.25843134 |
| 55 | MP0001188_hyperpigmentation | 1.25609790 |
| 56 | MP0009780_abnormal_chondrocyte_physiolo | 1.24684739 |
| 57 | MP0000383_abnormal_hair_follicle | 1.24673194 |
| 58 | MP0002136_abnormal_kidney_physiology | 1.17365888 |
| 59 | MP0002132_abnormal_respiratory_system | 1.17074329 |
| 60 | MP0002098_abnormal_vibrissa_morphology | 1.16692837 |
| 61 | MP0000013_abnormal_adipose_tissue | 1.16448486 |
| 62 | MP0005670_abnormal_white_adipose | 1.14931879 |
| 63 | MP0001849_ear_inflammation | 1.12003444 |
| 64 | MP0000470_abnormal_stomach_morphology | 1.10156424 |
| 65 | MP0009643_abnormal_urine_homeostasis | 1.08683564 |
| 66 | MP0004185_abnormal_adipocyte_glucose | 1.04368635 |
| 67 | MP0003252_abnormal_bile_duct | 1.04053658 |
| 68 | MP0001765_abnormal_ion_homeostasis | 1.02274646 |
| 69 | MP0003303_peritoneal_inflammation | 1.00827318 |
| 70 | MP0004858_abnormal_nervous_system | 0.99660167 |
| 71 | MP0004043_abnormal_pH_regulation | 0.98109203 |
| 72 | MP0000685_abnormal_immune_system | 0.97961968 |
| 73 | MP0010771_integument_phenotype | 0.97463788 |
| 74 | MP0001756_abnormal_urination | 0.97211511 |
| 75 | MP0000467_abnormal_esophagus_morphology | 0.96439002 |
| 76 | MP0004782_abnormal_surfactant_physiolog | 0.95900646 |
| 77 | MP0001764_abnormal_homeostasis | 0.94973157 |
| 78 | MP0005671_abnormal_response_to | 0.90793979 |
| 79 | MP0004270_analgesia | 0.89565017 |
| 80 | MP0005275_abnormal_skin_tensile | 0.89336485 |
| 81 | MP0004484_altered_response_of | 0.87370291 |
| 82 | MP0005166_decreased_susceptibility_to | 0.85149012 |
| 83 | MP0003806_abnormal_nucleotide_metabolis | 0.83686801 |
| 84 | MP0005666_abnormal_adipose_tissue | 0.82110175 |
| 85 | MP0000678_abnormal_parathyroid_gland | 0.81176355 |
| 86 | MP0004019_abnormal_vitamin_homeostasis | 0.79806447 |
| 87 | MP0003879_abnormal_hair_cell | 0.78493998 |
| 88 | MP0005058_abnormal_lysosome_morphology | 0.77084891 |
| 89 | MP0005636_abnormal_mineral_homeostasis | 0.76149455 |
| 90 | MP0005023_abnormal_wound_healing | 0.75976650 |
| 91 | MP0000230_abnormal_systemic_arterial | 0.75717490 |
| 92 | MP0000609_abnormal_liver_physiology | 0.75509183 |
| 93 | MP0002971_abnormal_brown_adipose | 0.74499045 |
| 94 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.73164067 |
| 95 | MP0000377_abnormal_hair_follicle | 0.72997203 |
| 96 | MP0002148_abnormal_hypersensitivity_rea | 0.72902743 |
| 97 | MP0001845_abnormal_inflammatory_respons | 0.71058244 |
| 98 | MP0005025_abnormal_response_to | 0.70962141 |
| 99 | MP0003724_increased_susceptibility_to | 0.69888531 |
| 100 | MP0001501_abnormal_sleep_pattern | 0.69417462 |
| 101 | MP0002139_abnormal_hepatobiliary_system | 0.69246809 |
| 102 | MP0005448_abnormal_energy_balance | 0.68757898 |
| 103 | MP0002166_altered_tumor_susceptibility | 0.68579059 |
| 104 | MP0003329_amyloid_beta_deposits | 0.68156148 |
| 105 | MP0009384_cardiac_valve_regurgitation | 0.67526015 |
| 106 | MP0002234_abnormal_pharynx_morphology | 0.67091794 |
| 107 | MP0001485_abnormal_pinna_reflex | 0.66852612 |
| 108 | MP0000465_gastrointestinal_hemorrhage | 0.66784628 |
| 109 | MP0002138_abnormal_hepatobiliary_system | 0.66444764 |
| 110 | MP0003950_abnormal_plasma_membrane | 0.65036420 |
| 111 | MP0005266_abnormal_metabolism | 0.64539264 |
| 112 | MP0008260_abnormal_autophagy | 0.64080055 |
| 113 | MP0005165_increased_susceptibility_to | 0.63235149 |
| 114 | MP0005310_abnormal_salivary_gland | 0.63078211 |
| 115 | MP0005319_abnormal_enzyme/_coenzyme | 0.62690027 |
| 116 | MP0006082_CNS_inflammation | 0.61779656 |
| 117 | MP0000367_abnormal_coat/_hair | 0.60211878 |
| 118 | MP0000613_abnormal_salivary_gland | 0.59907846 |
| 119 | MP0003868_abnormal_feces_composition | 0.59357041 |
| 120 | MP0002006_tumorigenesis | 0.58977250 |
| 121 | MP0002118_abnormal_lipid_homeostasis | 0.58820781 |
| 122 | MP0009840_abnormal_foam_cell | 0.57230282 |
| 123 | MP0003638_abnormal_response/metabolism_ | 0.57066426 |
| 124 | MP0000249_abnormal_blood_vessel | 0.56357229 |
| 125 | MP0005187_abnormal_penis_morphology | 0.55705828 |
| 126 | MP0008872_abnormal_physiological_respon | 0.55532272 |
| 127 | MP0005535_abnormal_body_temperature | 0.55307652 |
| 128 | MP0008873_increased_physiological_sensi | 0.53399524 |
| 129 | MP0009115_abnormal_fat_cell | 0.53180703 |
| 130 | MP0002896_abnormal_bone_mineralization | 0.52591990 |
| 131 | MP0001191_abnormal_skin_condition | 0.52335173 |
| 132 | MP0000343_altered_response_to | 0.51887179 |
| 133 | MP0001800_abnormal_humoral_immune | 0.51222952 |
| 134 | MP0009931_abnormal_skin_appearance | 0.50015010 |
| 135 | MP0000762_abnormal_tongue_morphology | 0.49523617 |
| 136 | MP0003566_abnormal_cell_adhesion | 0.48126528 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 7.45097407 |
| 2 | Right ventricular cardiomyopathy (HP:0011663) | 5.98073781 |
| 3 | Abnormal tarsal ossification (HP:0008369) | 5.90838787 |
| 4 | Flat acetabular roof (HP:0003180) | 5.67996999 |
| 5 | Abnormality of small intestinal villus morphology (HP:0011472) | 5.44443647 |
| 6 | Villous atrophy (HP:0011473) | 5.44443647 |
| 7 | Abnormality of the 1st metacarpal (HP:0010009) | 5.35605922 |
| 8 | Hydroxyprolinuria (HP:0003080) | 5.13517989 |
| 9 | Abnormality of proline metabolism (HP:0010907) | 5.13517989 |
| 10 | Pustule (HP:0200039) | 4.96670840 |
| 11 | Malnutrition (HP:0004395) | 4.37011101 |
| 12 | Metabolic alkalosis (HP:0200114) | 4.34798166 |
| 13 | Abnormal foot bone ossification (HP:0010675) | 4.32670855 |
| 14 | Cupped ribs (HP:0000887) | 4.22181098 |
| 15 | Abnormality of carpal bone ossification (HP:0006257) | 4.13538480 |
| 16 | Abdominal distention (HP:0003270) | 4.00353214 |
| 17 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.84590334 |
| 18 | Septate vagina (HP:0001153) | 3.78561118 |
| 19 | Woolly hair (HP:0002224) | 3.75730372 |
| 20 | Hyperactive renin-angiotensin system (HP:0000841) | 3.73781542 |
| 21 | Ileus (HP:0002595) | 3.73688683 |
| 22 | Short phalanx of the thumb (HP:0009660) | 3.70092593 |
| 23 | Fat malabsorption (HP:0002630) | 3.66079729 |
| 24 | Short 1st metacarpal (HP:0010034) | 3.51621840 |
| 25 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 3.51621840 |
| 26 | Abnormality of the 2nd finger (HP:0004100) | 3.48427365 |
| 27 | Fragile nails (HP:0001808) | 3.47349960 |
| 28 | Hypobetalipoproteinemia (HP:0003563) | 3.46670449 |
| 29 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.45116147 |
| 30 | Systemic lupus erythematosus (HP:0002725) | 3.39245509 |
| 31 | Ureteral stenosis (HP:0000071) | 3.36904898 |
| 32 | Chronic diarrhea (HP:0002028) | 3.22206337 |
| 33 | Increased IgE level (HP:0003212) | 3.21815070 |
| 34 | Abnormality of vitamin B metabolism (HP:0004340) | 3.18792824 |
| 35 | Confusion (HP:0001289) | 3.17246209 |
| 36 | Ureteral obstruction (HP:0006000) | 3.14153140 |
| 37 | Abnormal ossification of hand bones (HP:0005921) | 3.13809067 |
| 38 | Abnormal hand bone ossification (HP:0010660) | 3.06816334 |
| 39 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 3.06422448 |
| 40 | Plantar hyperkeratosis (HP:0007556) | 3.02433843 |
| 41 | Milia (HP:0001056) | 2.96575626 |
| 42 | Prostate neoplasm (HP:0100787) | 2.93463591 |
| 43 | Acanthocytosis (HP:0001927) | 2.90978492 |
| 44 | Decreased circulating renin level (HP:0003351) | 2.89654425 |
| 45 | Abnormality of renin-angiotensin system (HP:0000847) | 2.85584212 |
| 46 | Abnormality of vitamin metabolism (HP:0100508) | 2.85250094 |
| 47 | Congenital sensorineural hearing impairment (HP:0008527) | 2.82624973 |
| 48 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 2.81227744 |
| 49 | Abnormal hair laboratory examination (HP:0003328) | 2.80582561 |
| 50 | Eczematoid dermatitis (HP:0000976) | 2.76364281 |
| 51 | Petechiae (HP:0000967) | 2.70536611 |
| 52 | Hemorrhage of the eye (HP:0011885) | 2.70096275 |
| 53 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.69153719 |
| 54 | Abnormality of chloride homeostasis (HP:0011422) | 2.67916179 |
| 55 | Short hallux (HP:0010109) | 2.58612456 |
| 56 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.58084506 |
| 57 | Xanthomatosis (HP:0000991) | 2.56054451 |
| 58 | Alopecia of scalp (HP:0002293) | 2.55562765 |
| 59 | Cheilitis (HP:0100825) | 2.54323254 |
| 60 | Atrophic scars (HP:0001075) | 2.50829697 |
| 61 | Irregular epiphyses (HP:0010582) | 2.50240391 |
| 62 | Dehydration (HP:0001944) | 2.49422936 |
| 63 | Nausea (HP:0002018) | 2.47066259 |
| 64 | Onycholysis (HP:0001806) | 2.45166673 |
| 65 | Abnormality of nail color (HP:0100643) | 2.45081664 |
| 66 | Thick nail (HP:0001805) | 2.43518003 |
| 67 | Micronodular cirrhosis (HP:0001413) | 2.43086846 |
| 68 | Proximal tubulopathy (HP:0000114) | 2.38935285 |
| 69 | Steatorrhea (HP:0002570) | 2.38784102 |
| 70 | Erythema (HP:0010783) | 2.36795036 |
| 71 | Flattened epiphyses (HP:0003071) | 2.35845647 |
| 72 | Oligomenorrhea (HP:0000876) | 2.35527580 |
| 73 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.35051774 |
| 74 | Ventricular tachycardia (HP:0004756) | 2.33905108 |
| 75 | Hyperammonemia (HP:0001987) | 2.31944541 |
| 76 | Nephrolithiasis (HP:0000787) | 2.30275268 |
| 77 | Abnormality of urine glucose concentration (HP:0011016) | 2.30265720 |
| 78 | Glycosuria (HP:0003076) | 2.30265720 |
| 79 | Intrahepatic cholestasis (HP:0001406) | 2.30178751 |
| 80 | Oral leukoplakia (HP:0002745) | 2.30019604 |
| 81 | Wide cranial sutures (HP:0010537) | 2.29032560 |
| 82 | Neonatal short-limb short stature (HP:0008921) | 2.29009258 |
| 83 | Short middle phalanx of finger (HP:0005819) | 2.28075780 |
| 84 | Palmar hyperkeratosis (HP:0010765) | 2.27259422 |
| 85 | Flat capital femoral epiphysis (HP:0003370) | 2.26704092 |
| 86 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.25569601 |
| 87 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.25014583 |
| 88 | Vertebral hypoplasia (HP:0008417) | 2.25014583 |
| 89 | Palpitations (HP:0001962) | 2.24334128 |
| 90 | Hyperglycinuria (HP:0003108) | 2.23723657 |
| 91 | Conjugated hyperbilirubinemia (HP:0002908) | 2.22252218 |
| 92 | Pigmentary retinal degeneration (HP:0001146) | 2.20638715 |
| 93 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.19296827 |
| 94 | Spontaneous abortion (HP:0005268) | 2.18607155 |
| 95 | Palmoplantar hyperkeratosis (HP:0000972) | 2.18104984 |
| 96 | Hypotension (HP:0002615) | 2.17535051 |
| 97 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.16662483 |
| 98 | Abnormal vertebral ossification (HP:0100569) | 2.15668444 |
| 99 | Increased purine levels (HP:0004368) | 2.15341227 |
| 100 | Hyperuricemia (HP:0002149) | 2.15341227 |
| 101 | Hyponatremia (HP:0002902) | 2.11072248 |
| 102 | Gastrointestinal dysmotility (HP:0002579) | 2.10418826 |
| 103 | Breech presentation (HP:0001623) | 2.10304019 |
| 104 | Alkalosis (HP:0001948) | 2.09691423 |
| 105 | Abnormality of the costochondral junction (HP:0000919) | 2.08123255 |
| 106 | Parakeratosis (HP:0001036) | 2.07440400 |
| 107 | Vertebral clefting (HP:0008428) | 2.06276100 |
| 108 | Hypokalemia (HP:0002900) | 2.06172157 |
| 109 | Hypophosphatemia (HP:0002148) | 2.05679815 |
| 110 | Proximal placement of thumb (HP:0009623) | 2.05669432 |
| 111 | Epidermoid cyst (HP:0200040) | 2.05617348 |
| 112 | Biliary tract neoplasm (HP:0100574) | 2.04549284 |
| 113 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.01469228 |
| 114 | Abnormality of glycine metabolism (HP:0010895) | 2.01469228 |
| 115 | Deviation of the thumb (HP:0009603) | 2.01218231 |
| 116 | Pili torti (HP:0003777) | 2.00493214 |
| 117 | Hyperparathyroidism (HP:0000843) | 2.00041218 |
| 118 | Abnormal biliary tract morphology (HP:0012440) | 1.98710924 |
| 119 | Abnormality of purine metabolism (HP:0004352) | 1.98475185 |
| 120 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.97832225 |
| 121 | Dicarboxylic aciduria (HP:0003215) | 1.97832225 |
| 122 | Hyperphosphatemia (HP:0002905) | 1.96518096 |
| 123 | Hypotrichosis (HP:0001006) | 1.96062566 |
| 124 | Hypolipoproteinemia (HP:0010981) | 1.94776279 |
| 125 | Vacuolated lymphocytes (HP:0001922) | 1.94493949 |
| 126 | Glomerulosclerosis (HP:0000096) | 1.92719582 |
| 127 | Posterior subcapsular cataract (HP:0007787) | 1.91544450 |
| 128 | Renal tubular acidosis (HP:0001947) | 1.91421192 |
| 129 | Axonal loss (HP:0003447) | 1.91284797 |
| 130 | Genu varum (HP:0002970) | 1.90831809 |
| 131 | Enlarged epiphyses (HP:0010580) | 1.90401185 |
| 132 | Abnormal cartilage morphology (HP:0002763) | 1.90365518 |
| 133 | Abnormality of nucleobase metabolism (HP:0010932) | 1.89508516 |
| 134 | Abnormality of potassium homeostasis (HP:0011042) | 1.88684086 |
| 135 | Hypoglycemic coma (HP:0001325) | 1.86625721 |
| 136 | Aplasia/hypoplasia of the femur (HP:0005613) | 1.85749750 |
| 137 | Corneal erosion (HP:0200020) | 1.85749685 |
| 138 | Syncope (HP:0001279) | 1.85335204 |
| 139 | Growth hormone excess (HP:0000845) | 1.83929983 |
| 140 | Vascular calcification (HP:0004934) | 1.83515409 |
| 141 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.82753081 |
| 142 | Hoarse voice (HP:0001609) | 1.81503467 |
| 143 | Thin bony cortex (HP:0002753) | 1.80546515 |
| 144 | Abnormal blistering of the skin (HP:0008066) | 1.80021435 |
| 145 | Metaphyseal irregularity (HP:0003025) | 1.79662433 |
| 146 | Pterygium (HP:0001059) | 1.78112177 |
| 147 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.77413654 |
| 148 | Abnormality of T cell physiology (HP:0011840) | 1.77056290 |
| 149 | Focal segmental glomerulosclerosis (HP:0000097) | 1.76177233 |
| 150 | Widely patent fontanelles and sutures (HP:0004492) | 1.76049847 |
| 151 | Esophageal varix (HP:0002040) | 1.75240113 |
| 152 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.71889128 |
| 153 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.68762264 |
| 154 | Symptomatic seizures (HP:0011145) | 1.68613086 |
| 155 | Protuberant abdomen (HP:0001538) | 1.65146531 |
| 156 | Inflammation of the large intestine (HP:0002037) | 1.64885912 |
| 157 | Nail dystrophy (HP:0008404) | 1.64556305 |
| 158 | Curly hair (HP:0002212) | 1.63146907 |
| 159 | Hyperaldosteronism (HP:0000859) | 1.62011317 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST1R | 9.65514963 |
| 2 | PIK3CA | 5.71876556 |
| 3 | ACVR1B | 5.06807354 |
| 4 | ERN1 | 3.56633148 |
| 5 | MAP3K2 | 3.52971623 |
| 6 | MET | 3.51979121 |
| 7 | MST4 | 3.29549450 |
| 8 | MAP2K2 | 3.14131755 |
| 9 | FRK | 2.92039644 |
| 10 | KSR2 | 2.76830712 |
| 11 | EPHA2 | 2.34187503 |
| 12 | NME1 | 2.22076142 |
| 13 | MAP3K7 | 2.20259795 |
| 14 | EPHB2 | 2.18651343 |
| 15 | LMTK2 | 1.78208055 |
| 16 | TESK1 | 1.76796430 |
| 17 | ARAF | 1.57998546 |
| 18 | STK39 | 1.53078640 |
| 19 | MYLK | 1.49311202 |
| 20 | MAP2K1 | 1.47490007 |
| 21 | PIM2 | 1.46320633 |
| 22 | PRKG2 | 1.33206913 |
| 23 | CAMKK2 | 1.25315355 |
| 24 | PTK6 | 1.21610860 |
| 25 | PRPF4B | 1.19110800 |
| 26 | CAMK2D | 1.09037131 |
| 27 | TBK1 | 1.08226140 |
| 28 | STK11 | 1.05120460 |
| 29 | TAOK1 | 1.02745150 |
| 30 | MAP3K12 | 1.01200501 |
| 31 | PDK2 | 1.00591093 |
| 32 | OXSR1 | 0.92480001 |
| 33 | MAP3K1 | 0.91674984 |
| 34 | RPS6KB2 | 0.88132372 |
| 35 | IKBKE | 0.83558239 |
| 36 | MAP3K14 | 0.82283456 |
| 37 | EPHA4 | 0.78855428 |
| 38 | GRK6 | 0.78543542 |
| 39 | ERBB4 | 0.75441196 |
| 40 | TAOK3 | 0.75388750 |
| 41 | MATK | 0.75116916 |
| 42 | MAP3K11 | 0.74808254 |
| 43 | MAP3K8 | 0.74662994 |
| 44 | STK16 | 0.73890672 |
| 45 | TESK2 | 0.72401199 |
| 46 | LIMK1 | 0.70366219 |
| 47 | BMX | 0.70203117 |
| 48 | DMPK | 0.68428525 |
| 49 | STK10 | 0.67977956 |
| 50 | ITK | 0.66251224 |
| 51 | PRKAA2 | 0.66085380 |
| 52 | CDK9 | 0.60258195 |
| 53 | CDC42BPA | 0.60237539 |
| 54 | MAP3K3 | 0.59309862 |
| 55 | DAPK3 | 0.57869005 |
| 56 | MAP3K9 | 0.57741636 |
| 57 | FER | 0.55739236 |
| 58 | FGFR4 | 0.55533165 |
| 59 | RIPK4 | 0.54419952 |
| 60 | PRKCI | 0.50229214 |
| 61 | IRAK1 | 0.50225681 |
| 62 | PDGFRA | 0.50147132 |
| 63 | IRAK3 | 0.49441853 |
| 64 | TRIB3 | 0.48705197 |
| 65 | TEC | 0.48526725 |
| 66 | CHUK | 0.48368606 |
| 67 | DYRK1B | 0.46874722 |
| 68 | NLK | 0.46573388 |
| 69 | JAK2 | 0.46025022 |
| 70 | KDR | 0.43638742 |
| 71 | BRAF | 0.43045477 |
| 72 | EPHB1 | 0.42322516 |
| 73 | TTK | 0.41411911 |
| 74 | SMG1 | 0.41203702 |
| 75 | PTK2 | 0.40990016 |
| 76 | ZAP70 | 0.40565775 |
| 77 | MAPK11 | 0.39766932 |
| 78 | GRK1 | 0.39371279 |
| 79 | PRKACG | 0.37838771 |
| 80 | MAP3K6 | 0.37553011 |
| 81 | CAMKK1 | 0.37255980 |
| 82 | CAMK2G | 0.36988332 |
| 83 | MAP3K13 | 0.35988571 |
| 84 | CAMK1D | 0.35956296 |
| 85 | RET | 0.34307314 |
| 86 | TYK2 | 0.34160840 |
| 87 | PBK | 0.34144846 |
| 88 | CSK | 0.34091428 |
| 89 | GRK5 | 0.32927917 |
| 90 | MAP4K1 | 0.32417284 |
| 91 | MELK | 0.31593991 |
| 92 | CAMK2B | 0.31315295 |
| 93 | EPHA3 | 0.31264003 |
| 94 | CDK19 | 0.30558654 |
| 95 | IRAK4 | 0.29490996 |
| 96 | EEF2K | 0.28739185 |
| 97 | AKT3 | 0.28461801 |
| 98 | NEK6 | 0.28266661 |
| 99 | DDR2 | 0.28167766 |
| 100 | PDPK1 | 0.27608415 |
| 101 | PAK4 | 0.27512009 |
| 102 | PRKCZ | 0.27105834 |
| 103 | PIK3CG | 0.27070211 |
| 104 | SIK1 | 0.26833490 |
| 105 | PRKCA | 0.26673721 |
| 106 | RIPK1 | 0.26315136 |
| 107 | LRRK2 | 0.26261519 |
| 108 | PDGFRB | 0.25993193 |
| 109 | PRKAA1 | 0.25515343 |
| 110 | PAK1 | 0.25445272 |
| 111 | MAPK15 | 0.25360301 |
| 112 | PRKCD | 0.24413277 |
| 113 | MAPKAPK2 | 0.23940015 |
| 114 | SRC | 0.23328578 |
| 115 | ABL2 | 0.23104956 |
| 116 | TTN | 0.22658577 |
| 117 | ERBB2 | 0.21983555 |
| 118 | RAF1 | 0.21978448 |
| 119 | NUAK1 | 0.21792173 |
| 120 | ILK | 0.21639840 |
| 121 | MAPKAPK3 | 0.21529518 |
| 122 | MAP2K6 | 0.20559675 |
| 123 | STK24 | 0.19975553 |
| 124 | PKN2 | 0.19193469 |
| 125 | LCK | 0.18972732 |
| 126 | RPS6KA2 | 0.18496426 |
| 127 | PRKCQ | 0.17545359 |
| 128 | AURKB | 0.17253805 |
| 129 | PDK1 | 0.17099320 |
| 130 | MAP3K10 | 0.16305843 |
| 131 | MOS | 0.16193978 |
| 132 | PRKD2 | 0.16048573 |
| 133 | MUSK | 0.15982042 |
| 134 | BMPR2 | 0.15837697 |
| 135 | FGFR3 | 0.15512722 |
| 136 | FYN | 0.15498286 |
| 137 | BCR | 0.15228675 |
| 138 | TGFBR2 | 0.15151364 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur metabolism_Homo sapiens_hsa00920 | 7.59256175 |
| 2 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 4.64068681 |
| 3 | Mineral absorption_Homo sapiens_hsa04978 | 4.22332605 |
| 4 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.07814627 |
| 5 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.74368709 |
| 6 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.71377351 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.52931533 |
| 8 | Sulfur relay system_Homo sapiens_hsa04122 | 1.94533607 |
| 9 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.93628001 |
| 10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.92680573 |
| 11 | Histidine metabolism_Homo sapiens_hsa00340 | 1.88179899 |
| 12 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.85063387 |
| 13 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.80614871 |
| 14 | Bile secretion_Homo sapiens_hsa04976 | 1.75944498 |
| 15 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.69794689 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.69656913 |
| 17 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.68990088 |
| 18 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.60906261 |
| 19 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.58064036 |
| 20 | Galactose metabolism_Homo sapiens_hsa00052 | 1.48198096 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.45834956 |
| 22 | Parkinsons disease_Homo sapiens_hsa05012 | 1.40962309 |
| 23 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.40516207 |
| 24 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.39987394 |
| 25 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.39387764 |
| 26 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.36284094 |
| 27 | Alzheimers disease_Homo sapiens_hsa05010 | 1.35164707 |
| 28 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.33356075 |
| 29 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.31803745 |
| 30 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.30008312 |
| 31 | Thyroid cancer_Homo sapiens_hsa05216 | 1.28714889 |
| 32 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.27279249 |
| 33 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.23071555 |
| 34 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.21710827 |
| 35 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.20657570 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.18791421 |
| 37 | Tight junction_Homo sapiens_hsa04530 | 1.17892133 |
| 38 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.14991001 |
| 39 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.08741529 |
| 40 | Bladder cancer_Homo sapiens_hsa05219 | 1.05248825 |
| 41 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.02633104 |
| 42 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.02215197 |
| 43 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.98492702 |
| 44 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.88125976 |
| 45 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.87762001 |
| 46 | Hepatitis C_Homo sapiens_hsa05160 | 0.86721292 |
| 47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.85623560 |
| 48 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.85111520 |
| 49 | Salivary secretion_Homo sapiens_hsa04970 | 0.83845793 |
| 50 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.81721781 |
| 51 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.80597639 |
| 52 | Huntingtons disease_Homo sapiens_hsa05016 | 0.79743351 |
| 53 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.79578545 |
| 54 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.77891084 |
| 55 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.77806472 |
| 56 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.76681815 |
| 57 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.71695845 |
| 58 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.70665723 |
| 59 | Adherens junction_Homo sapiens_hsa04520 | 0.70550178 |
| 60 | Retinol metabolism_Homo sapiens_hsa00830 | 0.68847656 |
| 61 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.68211315 |
| 62 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.68200961 |
| 63 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.68005274 |
| 64 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.66749704 |
| 65 | Salmonella infection_Homo sapiens_hsa05132 | 0.66491132 |
| 66 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.64189725 |
| 67 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.64042341 |
| 68 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.62995811 |
| 69 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.62957884 |
| 70 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.62167224 |
| 71 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.61937039 |
| 72 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.61658219 |
| 73 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.60336740 |
| 74 | Other glycan degradation_Homo sapiens_hsa00511 | 0.59742028 |
| 75 | Asthma_Homo sapiens_hsa05310 | 0.59615939 |
| 76 | ABC transporters_Homo sapiens_hsa02010 | 0.56278144 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54661394 |
| 78 | Legionellosis_Homo sapiens_hsa05134 | 0.51478507 |
| 79 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.50242319 |
| 80 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.49954016 |
| 81 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.49925374 |
| 82 | Pertussis_Homo sapiens_hsa05133 | 0.49401119 |
| 83 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.48947208 |
| 84 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.47747939 |
| 85 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.47384214 |
| 86 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.47019224 |
| 87 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.46655876 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46198412 |
| 89 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.46197075 |
| 90 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.44774847 |
| 91 | Circadian rhythm_Homo sapiens_hsa04710 | 0.39450971 |
| 92 | Renin secretion_Homo sapiens_hsa04924 | 0.39191671 |
| 93 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.38360049 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.37794727 |
| 95 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.36970345 |
| 96 | Peroxisome_Homo sapiens_hsa04146 | 0.36933103 |
| 97 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.36861768 |
| 98 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.36269269 |
| 99 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.34664179 |
| 100 | Allograft rejection_Homo sapiens_hsa05330 | 0.33718318 |
| 101 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33081571 |
| 102 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.32012330 |
| 103 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.31396462 |
| 104 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.29658791 |
| 105 | Leishmaniasis_Homo sapiens_hsa05140 | 0.29259020 |
| 106 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.28754522 |
| 107 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.27907349 |
| 108 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.27855021 |
| 109 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.27783992 |
| 110 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.27607794 |
| 111 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.26568587 |
| 112 | Carbon metabolism_Homo sapiens_hsa01200 | 0.25792313 |
| 113 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.25694496 |
| 114 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.24768798 |
| 115 | Metabolic pathways_Homo sapiens_hsa01100 | 0.22434940 |
| 116 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.21821655 |
| 117 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.21642943 |
| 118 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.21543516 |
| 119 | Insulin resistance_Homo sapiens_hsa04931 | 0.20821846 |
| 120 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.20241895 |
| 121 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.18782495 |
| 122 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.18128324 |
| 123 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.17955724 |
| 124 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.17515418 |
| 125 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.17019282 |
| 126 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.16634416 |
| 127 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.14893864 |
| 128 | Amoebiasis_Homo sapiens_hsa05146 | 0.13914823 |
| 129 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.12431315 |
| 130 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.12150197 |
| 131 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.11377285 |
| 132 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.11085623 |
| 133 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.09429976 |
| 134 | Endocytosis_Homo sapiens_hsa04144 | 0.08107803 |
| 135 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.07126356 |
| 136 | Cocaine addiction_Homo sapiens_hsa05030 | 0.06673733 |
| 137 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.06589422 |

